Lupin and SteinCares Forge Strategic License and Supply Agreement to Commercialize Ranibizumab Biosimilar Across Latin America Global pharmaceutical leader Lupin Limited (Lupin) has officially announced the signing of a significant license and supply agreement with SteinCares, a prominent specialty healthcare…
WHO Launches Landmark Guideline to Bridge Global Gaps in Access to Controlled Medicines In a bold step toward improving global health equity, the World Health Organization (WHO) unveiled a new guideline aimed at helping countries strike a critical balance between…
Eisai’s Lemborexant (DAYVIGO®) Receives Regulatory Approval in China for the Treatment of Insomnia Eisai Co., Ltd., a leading global pharmaceutical company headquartered in Tokyo and led by CEO Haruo Naito, announced a significant milestone in its global expansion strategy with…
Bayer’s Eylea™ 8 mg Recommended for EU Approval with Extended 6-Month Treatment Interval for Major Retinal Diseases Bayer has today announced a significant milestone in the treatment of retinal diseases, revealing that the Committee for Medicinal Products for Human Use…
GSK’s Blenrep Combinations Receive Positive CHMP Opinion for Relapsed or Refractory Multiple Myeloma, Signaling Expanded Access Across Europe In a significant step forward for the treatment of multiple myeloma, GSK plc (LSE/NYSE: GSK) has announced that the Committee for Medicinal…
NICE Recommends FILSPARI® (sparsentan) for Routine Use in the NHS to Treat Adults with IgA Nephropathy, Marking a Significant Step Forward in Rare Kidney Disease Management CSL Vifor has announced a major regulatory and reimbursement milestone for its innovative kidney…
Bayer Launches Centafore Imaging Core Lab to Revolutionize Clinical Trial Imaging and SaMD Development Bayer, a global leader in healthcare and life sciences, today officially announced the launch of its Imaging Core Lab under the new brand name Centafore™. This…
Dr. Mark Stetter Elected to Zoetis Board of Directors, Bringing Decades of Veterinary Leadership and Animal Health Expertise Zoetis,a global leader in animal health, announced a significant addition to its governance with the election of Dr. Mark Stetter to its…
A Call for Change: Ensuring Access and Insurance Coverage for People Living with Obesity In recent months, abrupt changes to insurance coverage for obesity management medications have placed thousands of Americans living with obesity in an impossible situation. Many now…
AstraZeneca Showcases Broad Oncology Leadership with More Than 80 Abstracts and Two Plenary Presentations at ASCO 2025, Reinforcing Ambition to Eliminate Cancer as a Cause of Death AstraZeneca is poised to make a major impact at the 2025 American Society…
Sanofi to Acquire Vigil Neuroscience in $470 Million Deal, Bolstering Neurology Pipeline with Promising Alzheimer’s Drug Candidate In a strategic move that further solidifies its commitment to neurological disorders, Sanofi announced it has entered into a definitive agreement to acquire…
Grifols Secures FDA Clearance to Advance Immunoglobulin Eye Drops into Phase 2 Trial for Dry Eye Disease Grifols, a global leader in the production of plasma-derived medicines and a prominent name in the healthcare sector, has taken a pivotal step…